Cases
Representative Matters: Pfizer Inc., et al. v. Wockhardt, Ltd., et al., 12-CV-817 (SLR) (Consolidated) (D. Del.) Patent infringement action regarding Wockhardt's ANDA to make a generic version of Pfizer's antidepressant product Pristiq, the active ingredient of which is desvenlafaxine succinate. King Pharmaceuticals, Inc. et al. v. Actavis Inc., et al., Case No. 07-05041 (D.N.J. - G. Brown). Represented Actavis in ANDA litigation regarding AVINZA, the active ingredient of which is morphine sulfate. Pfizer Inc., et al. v. Mylan Pharmaceuticals, Inc., Case No. 10-00085 (D.Del. - J. Farnan). Represented Mylan in ANDA litigation involving Pfizer's cardiovascular product CADUET, the active ingredients of which are atorvastatin calcium
amlodipine besylate. Settled prior to trial. Shire LLC, et al. v. S
oz Inc., No. 11-CV-01110 (RBJ)(KMT) (D. Col.) Patent infringement action regarding S
oz's ANDA to make a generic version of Shire's ADHD product Intuniv, the active ingredient of which is guanfacine hydrochloride. Genentech, et al. v. S
oz, Case No. 11-CV-1925 (N.D.Cal. - J. White). Representing S
oz in ANDA litigation regarding VALCYTE, the active ingredient of which is valganciclovir. Medicis Pharmaceutical Corp. v. S
oz Inc., et al., Case No. 09-033 (JJF) (D Del.). Patent infringement action regarding S
oz's ANDA to make a generic version of Medicis's acne product Solodyn, the active ingredient of which is minocycline hydrochloride. Sepracor Inc. v. Teva Pharmaceuticals USA, Inc., et al., Case No. 09-CV-1302 (DMC)(D NJ). Patent infringement action regarding Wockhardt USA LLC's ANDA to make a generic version of Sepracor's insomnia product Lunesta, the active ingredient of which is eszopiclone. Sanofi-Aventis US LLC v. Barr Laboratories Inc., Case No. 06-CV-286 (D Del). Patent infringement action regarding Barr Laboratories' ANDA to make a generic version of sanofi's nasal allergy product Nasacort AQ, the active ingredient of which is triamcinolone. Endo Pharmaceuticals Inc. et al. v. S
oz, Inc., Case Nos. 08-534
08-970 (KSH) (D Del.). Patent infringement action regarding S
oz's ANDA to make a generic version of Endo's pain product Opana ER, the active ingredient of which is oxymorphone hydrochloride. Wyeth v. Apotex Inc.,
Apotex Corp., Case No. 08-022308 (S.D. Fla.). Patent infringement action regarding Apotex's ANDA to make a generic version of Wyeth's anti-depressant product EFFEXOR XR, the active ingredient of which is venlafaxine hydrochloride. Aventis Pharma S.A.
Sanofi-Aventis U.S. LLC v. Apotex Inc.
Apotex Corp., Case No. 08-496 (GMS) (D. Del. 2010). Patent infringement action regarding Apotex's ANDA to make a generic version of Sanofi-Aventis' anti-cancer product TAXOTERE, the active ingredient of which is docetaxel. Following a two-week trial, obtained an order for Apotex striking down the patents-in-issue as invalid
unenforceable due to Sanofi-Adventis' inequitable conduct in procuring the patents.
